Profile and quality of published reviews on COVID‐19

Pericàs, Juan M.; Torrallardona‐Murphy, Orla; Arenas, Andrea; Valero, Helena; Nicolás, David

doi:10.1111/eci.13293

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(31) However, an enormous amount of systematic reviews has been published, whose quality has already been appraised in a previous article. (32) This is a time-restrained review. In the near future, metaanalyses on most aspects of COVID-19 will probably become viable.…”

Section: ❚ Discussionmentioning

confidence: 99%

COVID-19 meta-analyses: a scoping review and quality assessment

Pires¹,

Bezerra²,

Oliveira³

et al. 2021

Einstein (São Paulo)

View full text Add to dashboard Cite

Objective: To carry out a scoping review of the meta-analyses published regarding about coronavirus disease 2019 (COVID-19), evaluating their main characteristics, publication trends and methodological quality. Methods: A bibliometric search was performed in PubMed ® , Scopus and Web of Science, focusing on meta-analyses about COVID-2019 disease. Bibliometric and descriptive data for the included articles were extracted and the methodological quality of the included metaanalyses was evaluated using A Measurement Tool to Assess Systematic Reviews. Results: A total of 348 meta-analyses were considered eligible. The first meta-analysis about COVID-19 disease was published on February 26, 2020, and the number of meta-analyses has grown rapidly since then. Most of them were published in infectious disease and virology journals. The greatest number come from China, followed by the United States, Italy and the United Kingdom. On average, these meta-analyses included 23 studies and 15,200 participants. Overall quality was remarkably low, and only 8.9% of them could be considered as of high confidence level. Conclusion: Although welldesigned meta-analyses about COVID-19 disease have already been published, the majority are of low quality. Thus, all stakeholders playing a role in COVID-19 deseases, including policy makers, researchers, publishers and journals, should prioritize well-designed meta-analyses, performed only when the background information seem suitable, and discouraging those of low quality or that use suboptimal methods.

show abstract

Section: ❚ Discussionmentioning

confidence: 99%

COVID-19 meta-analyses: a scoping review and quality assessment

Pires¹,

Bezerra²,

Oliveira³

et al. 2021

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

Quality of Systematic Reviews/Meta-Analyses in Coronavirus Disease 2019 and Venous Thromboembolism

Radhwi

Alkhamesi

Almohammadi

et al. 2022

Journal of Applied Hematology

View full text Add to dashboard Cite

BACKGROUND: Many systematic reviews (SRs) and meta-analyses (MAs) have been published regarding the incidence of venous thromboembolism (VTE) in coronavirus disease 2019 (COVID-19) patients, which is acknowledged as high. Therefore, we aimed to assess the methodological quality of any SR/MA involving VTE and COVID-19. METHODS: This is a meta-epidemiological study evaluating the methodological quality of SR/MA. A structured search in PubMed and Web of Science was done for all SRs/MAs in VTE and COVID-19 from inception till April 29, 2021. We evaluated the methodological quality using A Measurement Tool to Assess SRs-2 (AMSTAR-2) checklist. RESULTS: We included 29 SRs/MAs where only one SR/MA was rated as high (3.44%), 12 (41.37%) were rated as moderate, and the rest were rated as low/critically low (55.17%). No statistical significance was observed in Spearman's correlation analysis between the rate of methodological quality and the number of authors, searching period, publication month, and publishing journal's impact factor. CONCLUSIONS: The number of published SRs/MAs in the VTE and COVID-19 subject is rising rapidly. The readers should pay attention to the low methodological quality of most published SRs/MAs.

show abstract

Profile and quality of published reviews on COVID‐19

Cited by 2 publications

References 9 publications

COVID-19 meta-analyses: a scoping review and quality assessment

COVID-19 meta-analyses: a scoping review and quality assessment

Quality of Systematic Reviews/Meta-Analyses in Coronavirus Disease 2019 and Venous Thromboembolism

Contact Info

Product

Resources

About